bexarotene has been researched along with Hospital-Acquired Condition in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asteria, C | 1 |
1 review(s) available for bexarotene and Hospital-Acquired Condition
| Article | Year |
|---|---|
Treatment with retinoid X receptorgamma-selective ligand (bexarotene) may cause iatrogenic central hypothyroidism.
Topics: Animals; Bexarotene; Humans; Hypothyroidism; Iatrogenic Disease; Lymphoma, T-Cell; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes | 2000 |